April Mein Market Ka Mood Kaisa Hai?
Yaar, naye April series mein entry karte hi market ka outlook thoda bearish lag raha hai. Nifty apne 50-day aur 200-day moving averages ke neeche trade kar raha hai, jo cleary 'sell on rise' wala sign de raha hai. Matlab, jab bhi thoda upar aaye, toh bechne ka soch sakte ho. Analyst keh rahe hain ki market mein volatility rahegi, isliye investors ko light position rakhni chahiye.
March mein jo rollovers hue, usmein bhi zyada position cut-off dikha hai, naye buy-ins nahi. Isse lagta hai ki investors ka confidence kam hai April mein.
Pharma Sector Ne Maar Li Baazi!
Par jab baaki market gir raha hai, toh pharma sector kamaal kar raha hai! Aurobindo Pharma aur Sun Pharma jaise stocks bahut strong dikh rahe hain. Aurobindo Pharma ne toh apna 52-week high tod diya hai, ₹1359 tak pahunch gaya tha April 1, 2026 ko! Lagta hai pharma companies ab sirf quantity par nahi, quality par bhi focus kar rahi hain, research aur development mein bhi paisa laga rahi hain.
Stocks Ka Valuation Aur Performance
Ab valuation ki baat karein toh Sun Pharma ka P/E ratio 38.33x hai, jo thoda zyada hai Indian peers ke comparison mein. Wahi, Aurobindo Pharma ka P/E 21.51x ke aas-paas hai, jo sector ke average ke paas hai. Dr. Reddy's, Cipla, Lupin jaise competitors thode kam multiples par mil rahe hain.
Aurobindo Pharma pe analyst upgrade mil rahe hain, target 8% se zyada ka upside dikha rahe hain. Sun Pharma ka bhi consensus 'Buy' hai aur average target ₹1961 ke aas-paas hai.
Kahan Hai Concerns?
Bharat Electronics Limited (BEL) ka valuation kaafi high lag raha hai, P/E ratio 51.8x tak hai, jabki growth forecast market se kam rehne ki ummeed hai. Iske alawa, Sun Pharma ka 38.33x P/E bhi dekhne layak hai, matlab investors ko usse bahut zyada growth ki umeed hai.
ICICI Prudential Life Insurance Company bhi financial sector mein girawat ke karan vulnerable lag rahi hai.
Aage Kya Ho Sakta Hai?
Analysts Nifty ka long-term outlook toh achha bata rahe hain, FY27 tak 27,500 tak ja sakta hai. Nifty ka critical support 21,700 aur 22,000 ke beech hai.
Pharma sector innovation par focus kar raha hai, toh lagta hai aage bhi strong rahega. Aurobindo Pharma ke target ₹1360-₹1385 ke beech hain. Par yaad rakho, April mein volatility toh pakki hai!